Treatment for Neurodegenerative Diseases

Promoting Neuronal Regeneration 

The Discovery

UNSW researchers have identified a novel role for leukocyte immunoglobulin-like receptor (LILR) molecules which act to promote neuronal regeneration. This has the potential to treat a wide range of neurodegenerative diseases

Key Benefits

  • Naturally-occurring molecules to use as therapeutic intervention
  • Demonstrated efficacy in vitro

Applications

  • Multiple Sclerosis
  • Alzheimer’s Disease
  • Parkinson’s Disease
  • Amyotrophic Lateral Sclerosis
  • Motor Neuron Disease
  • Muscular Dystrophy
  • Huntington’s Disease
  • Spinal cord regeneration

 

The Opportunity

NewSouth Innovations has recently filed an Australian provisional patent around the technology and is actively seeking development and/or exclusive licensing partners.

 

Please click here to view a one-page Technology Brief

 

Patent Information:
For Information, Contact:
Alfredo Martinez-Coll
Senior Business Development Manager
NewSouth Innovations Pty Ltd
02 9385 4679
a.martinez-coll@unsw.edu.au
Reference ID: 13_2767
Inventors:
Nicodemus Tedla
Hongyan An
Katherine Bryant
Terry Lee
Keywords:
Biotech
CNS Diseases
Medical/Clinical
© 2017. All Rights Reserved. Powered by Inteum